Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Biologicals for Systemic Lupus Erythematosus market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Biologicals for Systemic Lupus Erythematosusmarket, defines the market attractiveness level of Biologicals for Systemic Lupus Erythematosus market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Biologicals for Systemic Lupus Erythematosus industry, describes the types of Biologicals for Systemic Lupus Erythematosus market, the applications of major players and the market size, and deeply analyzes the current situation of the global Biologicals for Systemic Lupus Erythematosus market and the development prospects and opportunities of Biologicals for Systemic Lupus Erythematosus industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Biologicals for Systemic Lupus Erythematosus market in Chapter 13.
By Player:
Shanghai Junshi Biosciences
GlaxoSmithKline
ACEA Biosciences
Roche
By Type:
Rituximab
Belimumab
Anifrolumab
UBP-1213
Other
By End-User:
Hospital
Clinic
Pharmacy
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Biologicals for Systemic Lupus Erythematosus Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Biologicals for Systemic Lupus Erythematosus Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Biologicals for Systemic Lupus Erythematosus Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Biologicals for Systemic Lupus Erythematosus Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Biologicals for Systemic Lupus Erythematosus Market Analysis and Outlook to 2022
-
7.1 Global Biologicals for Systemic Lupus Erythematosus Consumption (2017-2022)
-
7.2 United States Biologicals for Systemic Lupus Erythematosus Consumption (2017-2022)
-
7.3 Europe Biologicals for Systemic Lupus Erythematosus Consumption (2017-2022)
-
7.4 China Biologicals for Systemic Lupus Erythematosus Consumption (2017-2022)
-
7.5 Japan Biologicals for Systemic Lupus Erythematosus Consumption (2017-2022)
-
7.6 India Biologicals for Systemic Lupus Erythematosus Consumption (2017-2022)
-
7.7 South Korea Biologicals for Systemic Lupus Erythematosus Consumption (2017-2022)
8 Region and Country-wise Biologicals for Systemic Lupus Erythematosus Market Analysis and Outlook to 2028
-
8.1 Global Biologicals for Systemic Lupus Erythematosus Consumption Forecast (2022-2028)
-
8.2 United States Biologicals for Systemic Lupus Erythematosus Consumption Forecast (2022-2028)
-
8.3 Europe Biologicals for Systemic Lupus Erythematosus Consumption Forecast (2022-2028)
-
8.4 China Biologicals for Systemic Lupus Erythematosus Consumption Forecast (2022-2028)
-
8.5 Japan Biologicals for Systemic Lupus Erythematosus Consumption Forecast (2022-2028)
-
8.6 India Biologicals for Systemic Lupus Erythematosus Consumption Forecast (2022-2028)
-
8.7 South Korea Biologicals for Systemic Lupus Erythematosus Consumption Forecast (2022-2028)
9 Global Biologicals for Systemic Lupus Erythematosus Market Outlook by Types and Applications to 2022
-
9.1 Global Biologicals for Systemic Lupus Erythematosus Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Rituximab Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Belimumab Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Anifrolumab Consumption and Growth Rate (2017-2022)
-
9.1.4 Global UBP-1213 Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Biologicals for Systemic Lupus Erythematosus Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Pharmacy Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global Biologicals for Systemic Lupus Erythematosus Market Outlook by Types and Applications to 2028
-
10.1 Global Biologicals for Systemic Lupus Erythematosus Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Rituximab Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Belimumab Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Anifrolumab Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global UBP-1213 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Biologicals for Systemic Lupus Erythematosus Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Biologicals for Systemic Lupus Erythematosus Import and Export Analysis (Top 5 Countries)
-
11.1 Global Biologicals for Systemic Lupus Erythematosus Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Biologicals for Systemic Lupus Erythematosus Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Biologicals for Systemic Lupus Erythematosus Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Biologicals for Systemic Lupus Erythematosus Market Competitive Analysis
-
14.1 Shanghai Junshi Biosciences
-
14.1.1 Shanghai Junshi Biosciences Company Details
-
14.1.2 Shanghai Junshi Biosciences Biologicals for Systemic Lupus Erythematosus Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Shanghai Junshi Biosciences Biologicals for Systemic Lupus Erythematosus Product and Service
-
14.2 GlaxoSmithKline
-
14.2.1 GlaxoSmithKline Company Details
-
14.2.2 GlaxoSmithKline Biologicals for Systemic Lupus Erythematosus Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 GlaxoSmithKline Biologicals for Systemic Lupus Erythematosus Product and Service
-
14.3 ACEA Biosciences
-
14.3.1 ACEA Biosciences Company Details
-
14.3.2 ACEA Biosciences Biologicals for Systemic Lupus Erythematosus Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 ACEA Biosciences Biologicals for Systemic Lupus Erythematosus Product and Service
-
14.4 Roche
-
14.4.1 Roche Company Details
-
14.4.2 Roche Biologicals for Systemic Lupus Erythematosus Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Roche Biologicals for Systemic Lupus Erythematosus Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Biologicals for Systemic Lupus Erythematosus
-
Figure Biologicals for Systemic Lupus Erythematosus Picture
-
Table Global Biologicals for Systemic Lupus Erythematosus Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Biologicals for Systemic Lupus Erythematosus Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Biologicals for Systemic Lupus Erythematosus Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Biologicals for Systemic Lupus Erythematosus Consumption by Country (2017-2022)
-
Figure United States Biologicals for Systemic Lupus Erythematosus Consumption and Growth Rate (2017-2022)
-
Table Europe Biologicals for Systemic Lupus Erythematosus Consumption and Growth Rate (2017-2022)
-
Figure China Biologicals for Systemic Lupus Erythematosus Consumption and Growth Rate (2017-2022)
-
Figure Japan Biologicals for Systemic Lupus Erythematosus Consumption and Growth Rate (2017-2022)
-
Figure India Biologicals for Systemic Lupus Erythematosus Consumption and Growth Rate (2017-2022)
-
Figure South Korea Biologicals for Systemic Lupus Erythematosus Consumption and Growth Rate (2017-2022)
-
Figure Global Biologicals for Systemic Lupus Erythematosus Consumption Forecast by Country (2022-2028)
-
Figure United States Biologicals for Systemic Lupus Erythematosus Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Biologicals for Systemic Lupus Erythematosus Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Biologicals for Systemic Lupus Erythematosus Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Biologicals for Systemic Lupus Erythematosus Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Biologicals for Systemic Lupus Erythematosus Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Biologicals for Systemic Lupus Erythematosus Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rituximab Consumption and Growth Rate (2017-2022)
-
Figure Global Belimumab Consumption and Growth Rate (2017-2022)
-
Figure Global Anifrolumab Consumption and Growth Rate (2017-2022)
-
Figure Global UBP-1213 Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Pharmacy Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Rituximab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Belimumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anifrolumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global UBP-1213 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Biologicals for Systemic Lupus Erythematosus Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Biologicals for Systemic Lupus Erythematosus Export by Region (Top 5 Countries) (2017-2028)
-
Table Shanghai Junshi Biosciences (Foundation Year, Company Profile and etc.)
-
Table Shanghai Junshi Biosciences Biologicals for Systemic Lupus Erythematosus Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shanghai Junshi Biosciences Biologicals for Systemic Lupus Erythematosus Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Biologicals for Systemic Lupus Erythematosus Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Biologicals for Systemic Lupus Erythematosus Product and Service
-
Table ACEA Biosciences (Foundation Year, Company Profile and etc.)
-
Table ACEA Biosciences Biologicals for Systemic Lupus Erythematosus Sales, Price, Value and Gross Profit (2017-2022)
-
Table ACEA Biosciences Biologicals for Systemic Lupus Erythematosus Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Biologicals for Systemic Lupus Erythematosus Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Biologicals for Systemic Lupus Erythematosus Product and Service
-
